Concepedia

Author

M Gierend

University of Regensburg

Also Known As

Gierend, Michael, M Gierend, M-L Gierend, M. Gierend, Michael Gierend

32

Publications

610

Citations

13

H-Index

28

Concepts

All Affiliations

University of RegensburgSaarland UniversityOTH RegensburgMedicomp (United States)University Hospital Regensburg
MG

About

M Gierend is an author at University of Regensburg specializing in medicine, pharmacology, and gastroenterology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

287

2

Gastroenterology

4

4

181

3

Immunology

2

2

126

4

Health Sciences

1

1

18

5

Anesthesia

1

1

18

M Gierend

×

14

Publications

576

Citations

13

H-Index

YearCitations

Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.

Volker Groß, T. Andus, I. Caesar,

PubMed

1996

110

Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease

Tilo Andus, K. W. Ecker, Andreas Raedler,

Gut

1998

109

Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction

H-J Vogt, P Brandl, G. Kockott,

International Journal of Impotence Research

1997

72

Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease

Cornelia M. Gelbmann, Gerhard Rogler, M Gierend,

The American Journal of Gastroenterology

2002

56

Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group.

Tilo Andus, Wolfgang Fischbach, Achim Weber,

PubMed

1995

34

Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization

Hans Herfarth, Tilo Andus, I. Caesar,

International Journal of Colorectal Disease

2004

30

Reoperations at the ileostomy in Crohn's disease reflect inflammatory activity rather than surgical stoma complications alone

K. W. Ecker, M Gierend, D Kreissler-Haag,

International Journal of Colorectal Disease

2001

28

Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.

Angela Hammond, Tilo Andus, M Gierend,

PubMed

2004

27

Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.

I. Caesar, M.P. Roth, Tilo Andus,

PubMed

1997

24

Oral Budesonide Significantly Improves Water Absorption in Patients with Ileostomy for Crohn Disease

K. W. Ecker, Andreas Stallmach, Guido Seitz,

Scandinavian Journal of Gastroenterology

2003

22

Page 1